 |
ISBN
| 9780849318733 | |
DDC
| 615.19 | |
Nhan đề
| Pharmaceutical biotechnology / [Edited by] M J Groves | |
Lần xuất bản
| 2nd ed. | |
Thông tin xuất bản
| Boca Raton, FL : Taylor & Francis, 2006. | |
Mô tả vật lý
| 411 p. : illustrations ; cm. | |
Tóm tắt
| The book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without significant clinical effect. The book covers the market and scientific reasons behind the failure of many biotechnology products to live up to their hype. It concludes with a discussion of regulatory and compendial issues and a look at future challenges facing biotechnology. | |
Từ khóa tự do
| Pharmaceutical biotechnology. | |
Từ khóa tự do
| Biotechnology -- methods | |
Từ khóa tự do
| Technology, Pharmaceutical -- methods | |
Khoa
| Sách Giải trí - Tham khảo | |
Tác giả(bs) CN
| Klegerman, Melvin E. | |
Địa chỉ
| 100Q4_Kho Mượn(1): 078602 |
| |
000
| 00000nam#a2200000u##4500 |
|---|
| 001 | 33670 |
|---|
| 002 | 2 |
|---|
| 004 | D9923B8A-AD4D-4A25-87AF-7C34E1BF825F |
|---|
| 005 | 202204221453 |
|---|
| 008 | 211216s2006 flu eng |
|---|
| 009 | 1 0 |
|---|
| 020 | |a9780849318733|c5464000 |
|---|
| 039 | |a20220422145333|bquyennt|c20211216141238|dnghiepvu|y20211216141127|znghiepvu |
|---|
| 040 | |aNTT |
|---|
| 041 | |aeng |
|---|
| 044 | |aflu |
|---|
| 082 | |a615.19|bP5361b|223 |
|---|
| 245 | |aPharmaceutical biotechnology / |c[Edited by] M J Groves |
|---|
| 250 | |a2nd ed. |
|---|
| 260 | |aBoca Raton, FL : |bTaylor & Francis, |c2006. |
|---|
| 300 | |a411 p. : |billustrations ; |ccm. |
|---|
| 520 | |aThe book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without significant clinical effect. The book covers the market and scientific reasons behind the failure of many biotechnology products to live up to their hype. It concludes with a discussion of regulatory and compendial issues and a look at future challenges facing biotechnology. |
|---|
| 541 | |aMua |
|---|
| 653 | |aPharmaceutical biotechnology. |
|---|
| 653 | |aBiotechnology -- methods |
|---|
| 653 | |aTechnology, Pharmaceutical -- methods |
|---|
| 690 | |aSách Giải trí - Tham khảo |
|---|
| 700 | |aKlegerman, Melvin E.|eEditor |
|---|
| 852 | |a100|bQ4_Kho Mượn|j(1): 078602 |
|---|
| 856 | 1|uhttp://elib.ntt.edu.vn/documentdata01/2 tailieuthamkhao/600 congnghe/610 yhoc/anhbiasach/33670_pharmaceutical biotechnologythumbimage.jpg |
|---|
| 890 | |a1|b0|c0|d0 |
|---|
| |
| Dòng |
Mã vạch |
Nơi lưu |
S.gọi Cục bộ |
Phân loại |
Bản sao |
Tình trạng |
Thành phần |
Đặt chỗ |
|
1
|
078602
|
Q4_Kho Mượn
|
615.19 P5361b
|
Sách mượn tại chỗ
|
1
|
|
|
|
Không có liên kết tài liệu số nào
|
|
|
|